As the first substrate of AKT, GSK3β is involved in tumor formation and progression and acts as a tumor suppressor because its activation accelerates the degradation of oncogenes such as cyclin D1 and c-Myc.229. The gene discussed is GSK3B; the disease is neoplasm.